Published in Cancer Res on September 15, 1992
Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30
Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer (2004) 1.16
Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol (2007) 0.92
A novel rat model for chemotherapy-induced alopecia. Clin Exp Dermatol (2012) 0.84
Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia. BMC Pharmacol Toxicol (2013) 0.77
Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov (2015) 0.75
Chemotherapy-induced alopecia management: Clinical experience and practical advice. J Cosmet Dermatol (2017) 0.75
Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer (1977) 2.12
Blood dyscrasias and topical ophthalmic chloramphenicol. Am J Ophthalmol (1993) 2.04
Chloramphenicol-induced bone marrow suppression. Semin Hematol (1973) 1.79
Acquired pure red cell aplasia. Am J Hematol (1987) 1.38
Immunoblastic lymphadenopathy with mixed cryoglobulinemia. A detailed case study. N Engl J Med (1975) 1.15
Effect of chloramphenicol and thiamphenicol on the in vitro colony-forming cell. Blood (1974) 1.14
Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase. Int J Cancer (1978) 1.14
Purification of a colony-stimulating factor from cultured pancreatic carcinoma cells. J Biol Chem (1979) 1.03
Reversible bone marrow suppression from chloramphenicol. A consequence of mitochondrial injury. Arch Intern Med (1970) 1.01
Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry (1977) 1.01
Comparative effect of chloramphenicol and thiamphenicol on DNA and mitochondrial protein synthesis in mammalian cells. J Lab Clin Med (1973) 0.99
Purification and characterization of a colony stimulating factor from human lung. Biochemistry (1978) 0.99
Isoenzymes of glycogen phosphorylase in human leukocytes and platelets: relation to muscle phosphorylase. Biochem Biophys Res Commun (1968) 0.98
Common pattern of two distinct types of colony-stimulating factor in human tissues and cultured cells. J Clin Invest (1980) 0.96
Protection from chemotherapy-induced alopecia in a rat model. Science (1990) 0.96
Tumor-associated antigen in human pancreatic cancer. J Natl Cancer Inst (1979) 0.91
Interleukin 1 protects from cytosine arabinoside-induced alopecia in the rat model. FASEB J (1991) 0.90
The isolation and characterization of a colony stimulating factor from human lung. Biochim Biophys Acta (1977) 0.89
Chloramphenicol-related changes in mitochondrial ultrastructure. J Cell Sci (1970) 0.87
Chloramphenicol-induced erythroid suppression and bone marrow ferrochelatase activity in dogs. J Lab Clin Med (1972) 0.87
The secretion of fibrinolysin by cultured rat ovarian tumor cells. Biochem Biophys Res Commun (1973) 0.85
Lipoxygenation of arachidonic acid by differentiated and undifferentiated human promyelocytic HL-60 cells. J Lab Clin Med (1986) 0.84
Chloramphenicol and protein synthesis in mammalian cells. J Lab Clin Med (1968) 0.83
Prominent glutamine oxidation activity in mitochondria of hematopoietic tumors. Cancer Res (1983) 0.83
Comparative metabolic effects of chloramphenicol analogues. Mol Pharmacol (1975) 0.82
The effect of chloramphenicol treatment on ferrochelatase activity in dogs. Biochem Biophys Res Commun (1970) 0.82
Sodium-potassium dependent adenosine triphosphatase of mammalian reticulocytes and mature red blood cells. Proc Soc Exp Biol Med (1966) 0.81
Drug-induced red cell dyscrasias. Blood Rev (1989) 0.81
Comparative metabolic effects of chloramphenicol and thiamphenicol in mammalian cells. Postgrad Med J (1974) 0.81
Heterogeneity of human colony-forming cells (CFU-C): differences in size, rate of colony formation, and responsiveness to colony-stimulating factor. J Lab Clin Med (1978) 0.81
Immunologic relationship among fibrinolysins secreted by cultured mammalian tumor cells. Exp Cell Res (1975) 0.80
Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2). J Natl Cancer Inst (1986) 0.80
Purification and characterization of human colony-stimulating factor 1 from human pancreatic carcinoma (MIA PaCa-2) cells. Arch Biochem Biophys (1987) 0.80
Protection from 1-beta-D-arabinofuranosylcytosine-induced alopecia by epidermal growth factor and fibroblast growth factor in the rat model. Cancer Res (1992) 0.80
Vitamin D3 and chemotherapy-induced alopecia. Nutrition (1996) 0.79
Pretreatment with 1,25(OH)2D3 protects from Cytoxan-induced alopecia without protecting the leukemic cells from Cytoxan. Am J Med Sci (1995) 0.79
Isolation of colony stimulating factor from human milk. Biochem Biophys Res Commun (1983) 0.79
The cellular transport of chloramphenicol and thiamphenicol. J Lab Clin Med (1977) 0.79
Mitochondrial metabolism in normal, myeloid, and erythroid hyperplastic rabbit bone marrow: effect of chloramphenicol. Am J Hematol (1980) 0.79
Bone marrow aplasia following propylthiouracil therapy. Report of a case with complete recovery. Arch Intern Med (1967) 0.79
Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma. Int J Biochem (1979) 0.78
The nitroreduction of chloramphenicol by human liver tissue. J Lab Clin Med (1981) 0.78
Induced release and metabolism of arachidonic acid from myeloid cells by purified colony-stimulating factor. J Cell Physiol (1982) 0.78
Nitroso-chloramphenicol: possible mediator in chloramphenicol-induced aplastic anemia. J Lab Clin Med (1980) 0.78
Characteristics of rat carcinoma in culture. Cancer Res (1975) 0.78
Chloramphenicol and bone marrow mitochondria. J Lab Clin Med (1969) 0.78
Subunit structure and amino-acid composition of crystallized human-muscle glycogen phosphorylase. Eur J Biochem (1973) 0.78
Modulation of colony stimulating factor-induced murine myeloid colony formation by S-peptido-lipoxygenase products. Cancer Res (1986) 0.78
The inhibitory effects of teniposide and homoharringtonine on the growth of pancreatic carcinoma cells in vitro. Anticancer Res (1988) 0.78
Congenital neutropenia: a case study. Am J Pediatr Hematol Oncol (1990) 0.78
Drug-induced inhibition of myeloid colony growth: protective effect of colony-stimulating factor. J Lab Clin Med (1975) 0.77
DNA damage in intact cells induced by bacterial metabolites of chloramphenicol. Am J Hematol (1988) 0.77
Enzymes of glycogen metabolism in white blood cells. II. Activation and inactivation of glycogen phosphorylase of rat chloroma. Biochim Biophys Acta (1966) 0.77
Discriminatory effects of gold compounds and carriers on mitochondria isolated from different tissues. Biochem Pharmacol (1981) 0.77
Importance of the mitochondrial amino acid pool in the sensitivity of erythroid cells to chloramphenicol: role of glycine and serine. Pharmacology (1987) 0.77
Tumor cell rejection through terminal cell differentiation. Science (1987) 0.77
Treatment with monocyte-derived partially purified GM-CSF but not G-CSF aborts the development of transplanted chloroleukemia in rats. Blood (1988) 0.77
Drug-induced mitochondrial damage and sideroblastic change. Clin Haematol (1980) 0.77
Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501). Cancer Res (1981) 0.77
Arachidonic acid metabolism by rat chloroleukemia cells in culture. Cancer Res (1981) 0.77
Heterogeneity of human colony-forming cells (CFUc) with respect to their sensitivity to chloramphenicol. Exp Hematol (1980) 0.77
Protection from chemotherapy-induced neutropenia by ImuVert. Am J Med Sci (1992) 0.77
Interleukin 1 protects hair follicles from cytarabine (ARA-C)-induced toxicity in vivo and in vitro. FASEB J (1992) 0.76
Chloramphenicol-mediated DNA damage and its possible role in the inhibitory effects of chloramphenicol on DNA synthesis. J Lab Clin Med (1983) 0.76
DNA damage induced by chloramphenicol and its nitroso derivative: damage in intact cells. Am J Hematol (1987) 0.76
In vitro evidence for genetically determined variations in marrow erythroid cell sensitivity to chloramphenicol. Exp Hematol (1978) 0.76
Degradation of isolated deoxyribonucleic acid mediated by nitroso-chloramphenicol. Possible role in chloramphenicol-induced aplastic anemia. Biochem Pharmacol (1982) 0.76
Stability of chloramphenicol metabolites in human blood and liver as determined by high-performance liquid chromatography. Pharmacology (1988) 0.76
Modulation of granulopoiesis: opposing roles of prostaglandins F and E. J Lab Clin Med (1978) 0.76
Chloramphenicol toxicity: pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia. Clin Toxicol (1980) 0.76
Further evidence supporting an in vivo role for colony-stimulating factor. Exp Hematol (1984) 0.76
Drug-induced bone marrow aplasia. Rev Bras Pesqui Med Biol (1978) 0.76
Establishment and cell cycle kinetics of a human squamous cell carcinoma in nude mice and in vitro. Cancer Res (1981) 0.76
Chloramphenicol-induced bone marrow injury: possible role of bacterial metabolites of chloramphenicol. Blood (1987) 0.75
Immunological and functional differences between human type I and II colony-stimulating factors. J Clin Invest (1981) 0.75
Treatment with ImuVert/N-acetylcysteine protects rats from cyclophosphamide/cytarabine-induced alopecia. Cancer Invest (1992) 0.75
Purification of human granulocyte-macrophage progenitor cells (CFU-C) using indirect immunofluorescence and cell sorting. Stem Cells (1982) 0.75
Antibody to purified human colony-stimulating factor: use in the identification and isolation of granulocyte macrophage progenitor cells. Blood Cells (1980) 0.75
On the mechanisms of erythroid cell sensitivity to chloramphenicol: studies on mitochondria isolated from erythroid and myeloid tumors. Arch Biochem Biophys (1981) 0.75
Effect of Monase and related compounds on uptake of 5-hydroxytryptamine by platelets. Proc Soc Exp Biol Med (1966) 0.75
Application of thermospray liquid chromatography-mass spectrometry for the analysis of chloramphenicol and three related compounds. J Chromatogr Sci (1990) 0.75
Sensitivity of cultured pancreatic carcinoma cells to Acinetobacter glutaminase-asparaginase. In Vitro (1982) 0.75
An oligomycin-resistant Mg2+-dependent ATPase in rabbit bone marrow mitochondria. Mol Cell Biochem (1982) 0.75
Purification of a colony stimulating factor from culture cell lines propagated from human lung. FEBS Lett (1978) 0.75
Differential in vitro sensitivity of marrow erythroid and granulocytic colony forming cells to chloramphenicol. Am J Hematol (1977) 0.75
Treatment with Imuvert aborts development of chloroleukemia in newborn rats. J Biol Response Mod (1990) 0.75
Physicochemical and catalytic properties of crystallized human muscle glycogen phosphorylase. Ann N Y Acad Sci (1973) 0.75
Differential effects of chloramphenicol and its nitrosoanalogue on protein synthesis and oxidative phosphorylation in rat liver mitochondria. Biochem Pharmacol (1980) 0.75
Interaction of chloramphenicol and metabolites with colony stimulating factors: possible role in chloramphenicol-induced bone marrow injury. Am J Med Sci (1990) 0.75
Inhibition of Ca2+ of oxidative phosphorylation in myeloid tumor mitochondria. Arch Biochem Biophys (1981) 0.75
Nitroso-chloramphenicol: cell cycle specificity of action. Pharmacology (1982) 0.75
Reversal of in vitro drug induced myeloid suppression by lithium. Exp Hematol (1981) 0.75
Familial infantile thrombotic thrombocytopenic purpura. J Pediatr Hematol Oncol (1996) 0.75
Synergism of ara-C-imuvert combination in aborting the development of transplanted chloroleukemia in the rat. Am J Med Sci (1991) 0.75
Enzymes of glycogen metabolism in white blood cells. 3. Heterogeneity of glycogen phosphorylase from rat chloroma. Biochim Biophys Acta (1966) 0.75
Alteration of prostaglandin biosynthesis in rat chloroleukemic tumor. Cancer Res (1977) 0.75
Biochemical lesion in Dilantin-induced erythroid aplasia. Blood (1967) 0.75
The cellular uptake and covalent binding of nitroso-chloramphenicol. J Lab Clin Med (1981) 0.75
Aerobic nitroreduction of dehydrochloramphenicol by bone marrow. Toxicol Appl Pharmacol (1988) 0.75
Characteristics of fibrinolysin secreted by cultured rat breast carcinoma cells. Exp Cell Res (1975) 0.75